U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT06884098) titled 'A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284' on March 13.
Brief Summary: Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-228B in healthy subjects.
Study Start Date: March 10
Study Type: INTERVENTIONAL
Condition:
Primary Hypercholesterolaemia
Intervention:
DRUG: AD-228B
AD-228B, 1Tab., Per Oral
DRUG: AD-2284
AD-2284, 1Tab., Per Oral
Recruitment Status: RECRUITING
Sponsor: Addpharma Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....